Prader-Willi Syndrome: all 142 studies
Page 1 of 2. Open to participants first (23), then studies with results posted, then the rest; newest registration first within each.
- Regulating Together for Prader-Willi Syndrome: A Group Behavioral Therapy for Emotion DysregulationRecruitingNCT07607730Not applicable
- Observational Study of VYKAT™ XR in Patients With Prader-Willi SyndromeEnrolling by invitationNCT07450664
- A Study of CSTI-500 in Patients With Prader-Willi SyndromeRecruitingNCT07348601Phase 2
- A 2-Part Study to Assess Efficacy, Safety and Tolerability of BMB-101 for the Treatment of Patients With Prader-Willi Syndrome.Not yet recruitingNCT07266324Phase 2
- A Study of Pitolisant in Participants With Prader-Willi SyndromeEnrolling by invitationNCT07219485Phase 3
- Oromyofunctional Therapy: a Rehabilitation Program for OSA in Children With Down Syndrome and Prader-Willi SyndromeRecruitingNCT07122505Not applicable
- Brain Olfactory Pathways in Prader-Willi SyndromeNot yet recruitingNCT07006207Not applicable
- Tirzepatide in PWS, HO and GNSORecruitingNCT06901245Phase 4
- Autistic Symptomatology and Sensory Profile in Children With Prader-Willi SyndromeRecruitingNCT06877715
- Physical Activity and Community EmPOWERment ProjectRecruitingNCT06740162Not applicable
- Effects of Transcutaneous Vagus Nerve Stimulation on Emotion Regulation and Executive Functioning in Prader-Willi SyndromeRecruitingNCT06720571Not applicable
- Institutional Registry of Rare DiseasesRecruitingNCT06573723
- A Study of Pitolisant in Patients With Prader-Willi SyndromeRecruitingNCT06366464Phase 3
- Adolescent Projections During Transition in Prader-Willi SyndromeNot yet recruitingNCT06279052Not applicable
- IDMet (RaDiCo Cohort) (RaDiCo-IDMet)RecruitingNCT05945576
- Cerebellar TMS and Satiety in Prader-Willi SyndromeRecruitingNCT05938543Not applicable
- The Intervention of Obesity in Children With Prader-Willi Syndrome Using Prebiotics and ProbioticsRecruitingNCT05791604Not applicable
- Long-term Interventional Follow-up Study of Children With Prader-Willi Syndrome Included in the OTBB3 Clinical TrialRecruitingNCT05032326Phase 3
- Ghrelin in Patients With a Rare Disease Associated With Intellectual Disability, and Hyperphagia, and/or Overweight, and/or ObesityRecruitingNCT04768803
- Growth Hormone Study in Adults With Prader-Willi SyndromeNot yet recruitingNCT04484051
- GROWing Up With Rare GENEtic SyndromesRecruitingNCT04463316
- Parent and Infant Inter(X)Action Intervention (PIXI)Enrolling by invitationNCT03836300Not applicable
- Register of Patients With Prader-Willi SyndromeRecruitingNCT02829684
- Understanding the Role of Gut Microbiota in Hyperphagia in Prader-Willi SyndromeCompletedNCT05541003Phase 2Results posted
- A Study of Oral ARD-101 in Patients With Prader-Willi SyndromeCompletedNCT05153434Phase 2Results posted
- A Study to Assess RAD011 (Cannabidiol Oral Solution) for the Treatment of Participants With Prader-Willi SyndromeTerminatedNCT05098509Phase 2/3Results posted
- Study of the Efficacy and Safety of Somatropin in Japanese Participants With PWSCompletedNCT04697381Phase 3Results posted
- A Phase 2 Study to Evaluate the Safety and Efficacy of Pitolisant in Patients With Prader-Willi Syndrome, Followed by an Open Label ExtensionCompletedNCT04257929Phase 2Results posted
- CBDV vs Placebo in Children and Adults up to Age 30 With Prader-Willi Syndrome (PWS)TerminatedNCT03848481Phase 2Results posted
- Effects of Livoletide (AZP-531) on Food-related Behaviors in Patients With Prader-Willi SyndromeTerminatedNCT03790865Phase 2/3Results posted
- Phase 3 Study of Intranasal Carbetocin (LV-101) in Patients With Prader-Willi SyndromeCompletedNCT03649477Phase 3Results posted
- A Study to Assess the Long-Term Safety of Pharmaceutical Grade Synthetic Cannabidiol Oral Solution in Participants With Prader-Willi SyndromeTerminatedNCT03458416Phase 2Results posted
- A Study of Diazoxide Choline in Patients With Prader-Willi SyndromeCompletedNCT03440814Phase 3Results posted
- A Study of GLWL-01 in Patients With Prader-Willi SyndromeCompletedNCT03274856Phase 2Results posted
- Intranasal Oxytocin for Infants With Prader-Willi SyndromeCompletedNCT03245762Phase 1/2Results posted
- Intranasal Oxytocin vs. Placebo for the Treatment of Hyperphagia in Prader-Willi SyndromeCompletedNCT03197662Phase 2Results posted
- Co-administration of Tesofensine/Metoprolol in Subjects With Prader-Willi Syndrome (PWS)CompletedNCT03149445Phase 2Results posted
- Cannabidiol Oral Solution for the Treatment of Patients With Prader-Willi SyndromeTerminatedNCT02844933Phase 2Results posted
- Oxytocin vs. Placebo for the Treatment Hyperphagia in Children and Adolescents With Prader-Willi SyndromeCompletedNCT02629991Phase 2Results posted
- Effect of Liraglutide for Weight Management in Paediatric Subjects With Prader-Willi SyndromeCompletedNCT02527200Phase 3Results posted
- Phase 2 Trial to Evaluate Safety and Efficacy of Setmelanotide (RM-493) in Obese Participants With Prader-Willi SyndromeCompletedNCT02311673Phase 2Results posted
- Evaluation of Tolerance, Suckling and Food Intake After Repeated Nasals Administrations of Oxytocin in PWS InfantsCompletedNCT02205034Phase 1/2Results posted
- Treatment of Hyperphagia Behavioral Symptoms in Children and Adults Diagnosed With Prader-Willi SyndromeCompletedNCT01968187Phase 2Results posted
- Pilot Study of Startle-response Test to Assess Transcranial Direct Current Stimulation-induced Modulation of Hyperphagia in Prader-Willi SyndromeCompletedNCT01863017Not applicableResults posted
- Effects of Exenatide on Overweight Adolescents With Prader-Willi SyndromeCompletedNCT01444898Not applicableResults posted
- Growth Hormone Use in Adults With Prader-Willi SyndromeCompletedNCT00444964Phase 3Results posted
- Octreotide Therapy in Children and Young Adults With Prader-Willi Syndrome (PWS)TerminatedNCT00399893Not applicableResults posted
- The Hunger Elimination or Reduction Objective (HERO ) Open -Label Extension (OLE) TrialTerminatedNCT07197034Phase 3
- Functional Connectome in Prader-Willi Syndrome: Neuroimaging and AI to Assess Therapeutic ImpactCompletedNCT06900335
- Respiratory Restriction in Prader-Willi SyndromeCompletedNCT06851351
- ARD-101 for Treatment of PWS: The Hunger Elimination or Reduction Objective TrialTerminatedNCT06828861Phase 3
- A Study of Setmelanotide in Patients With Prader-Willi SyndromeActive, not recruitingNCT06772597Phase 2
- Ultrasound to Assess Sarcopenia in Prader Willi SyndromeCompletedNCT06448871
- Evaluation of the Psychological Profile of Adult Patients With Prader-Willi SyndromeCompletedNCT06295315
- A Study of RM-718 in Healthy Subjects and Patients With MC4R Pathway ImpairmentActive, not recruitingNCT06239116Phase 1/2
- A Clinical Evaluation of Non-Invasive Vagus Nerve Stimulation for Temper Outbursts in People With PWSActive, not recruitingNCT06144645Phase 3
- Impact of Bright Light Therapy on Prader-Willi SyndromeActive, not recruitingNCT05939453Not applicable
- An Open-Label Study of Oral NNZ-2591 in Prader-Willi Syndrome (PWS-001)WithdrawnNCT05879614Phase 2
- Development of a Newborn Screening Assay for Angelman Syndrome and Prader-Willi SyndromeCompletedNCT05783791
- Biological Age Assessment in Adults With Prader-Willi Syndrome (ETABIOLPWS)Active, not recruitingNCT05778032
- Characterization of Serum Proteome in Subjects With Prader Willi Syndrome (PROTEOMARKER)CompletedNCT05761184
- Open-Label Extension Study of DCCR in Patients With Prader-Willi SyndromeCompletedNCT05701774Phase 3
- Guanfacine Extended Release for the Reduction of Aggression and Self-injurious Behavior Associated With Prader-Willi SyndromeCompletedNCT05657860Phase 4
- A Pharmacokinetic and Safety Study of CSTI-500 in Subjects With Prader-Willi SyndromeCompletedNCT05504395Phase 1
- A Phase 3 Extension Study of RAD011 (Cannabidiol Oral Solution) in Patients With Prader-Willi SyndromeWithdrawnNCT05387798Phase 3
- Study to Evaluate Efficacy, Safety, and Tolerability of RGH-706 in Prader-Willi SyndromeCompletedNCT05322096Phase 2
- Effect of Intranasal Oxytocin on Dysphagia in Children and Adolescents With Prader-Willi SyndromeCompletedNCT05298085Phase 2/3
- Improving Care of Prader-Willi Syndrome : Evaluation of a New Care Program Combining Adapted Physical Activity, Nutrition and Therapeutic EducationCompletedNCT05249998Not applicable
- Study of Tesomet With Open-label Extension in Subjects With Prader-Willi SyndromeWithdrawnNCT05198362Phase 2
- Effect of Deep Propioceptive Stimulation in Prader-Willi SyndromeCompletedNCT05044000Not applicable
- Assessment of CAI in Adults With PWS.CompletedNCT04700644
- Probiotic Treatment for Prader-Willi SyndromeCompletedNCT04685057Not applicable
- Prader-Willi Syndrome Body CompositionCompletedNCT04597645Not applicable
- Study of Emotion and Cognition Abilities of Children With PWS and Proposition of an Innovative RemediationCompletedNCT04526379Not applicable
- tVNS in Children With Prader-Willi SyndromeWithdrawnNCT04396470Phase 1/2
- Oxytocin Treatment in Neonates and Infants With Prader-Willi SyndromeCompletedNCT04283578Phase 3
- Fiber Intervention on Gut Microbiota in Children With Prader-Willi SyndromeCompletedNCT04150991Not applicable
- Autonomic Regulation in Prader-Willi SyndromeStatus unknownNCT04118816
- PWS Outcomes Assessment StudyCompletedNCT04102839
- An Open-Label Study of DCCR Tablet in Patients With PWSWithdrawnNCT04086810Phase 3
- Dose Clinical Trial of Guanfacine Extended Release for the Reduction of Aggression and Self-injuries Behavior Associated With Prader-Willi SyndromeWithdrawnNCT04066088Phase 4
- Stress and Brain Response Using MEG in PWSStatus unknownNCT04032639
- Home-based SSP on Individuals With PWSTerminatedNCT03871751Not applicable
- Therapeutic Effects of Hippotherapy in Children With Prader-Willi SyndromeStatus unknownNCT03858023Not applicable
- Mitochondrial Complex I Dysfunction in PWSWithdrawnNCT03831425Phase 2
- Natural History Study of Serious Medical Events in PWSCompletedNCT03718416
- Open-Label Extension Study of DCCR in PWS Followed by Double-Blind, Placebo-Controlled, Randomized Withdrawal PeriodCompletedNCT03714373Phase 3
- Proof of Concept Study of Vagus Nerve StimulationCompletedNCT03689621Not applicable
- Early Check: Expanded Screening in NewbornsActive, not recruitingNCT03655223
- GH in Adults With PWS, Effect on Hypotonia Evaluated by Functional MRI, Relationship With Strength and Body CompositionCompletedNCT03616509Phase 4
- Effects of Progressive Elastic Band Resistance TrainingCompletedNCT03565081Not applicable
- A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone Injection in Patients With Prader-Willi SyndromeStatus unknownNCT03554031Phase 3
- Targeting the Gut Microbiome for Prader-Willi Syndrome TreatmentCompletedNCT03548480Not applicable
- Effects of Transcranial Direct Current Stimulation (tDCS) on Individuals With Prader-Willi SyndromeStatus unknownNCT03324906Not applicable
- Oxytocin Intranasal Administrations in Children With Prader-Willi Syndrome Aged From 3 to 12 YearsCompletedNCT03114371Not applicable
- Optimizing the Social Engagement System in Prader-Willi Syndrome: Insights From the Polyvagal TheoryTerminatedNCT03101826Not applicable
- Follow-up of Prader Willi Syndrome Infants Treated by Oxytocin and Comparison With Not-treated Infants.CompletedNCT03081832Not applicable
- Oxygen Versus Medical Air for Treatment of CSA in Prader Will SyndromeCompletedNCT03031626Phase 4
- A 5 Treatment Period Pharmacokinetic Study Evaluating Dose Proportionality and Food Effects of Diazoxide Choline Controlled-Release Tablet (DCCR)Status unknownNCT02893618Phase 2
- Study of the Efficacy of Topiramate in Patients With Prader Willi Syndrome Over 8 WeeksTerminatedNCT02810483Phase 3